STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] CYBIN INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Cybin Inc. (CYBN): Venrock-affiliated entities and individuals filed a Schedule 13G reporting beneficial ownership of 5,111,412 common shares, representing 9.99% of the class as of the 10/31/2025 event date.

The stake comprises common shares plus pre-funded warrants and common warrants, all subject to a 9.99% Beneficial Ownership Blocker. The percentage is based on 27,616,381 common shares outstanding as of 10/28/2025, 22,277,750 shares issued in a registered direct offering that closed on 10/31/2025, and 1,271,162 shares issuable upon warrant exercise. Cover-page percentages are rounded down to 9.9% due to EDGAR limits.

The reporting group includes Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, L.L.C., Venrock Healthcare Capital Partners EG, L.P., their managers, and individuals Nimish Shah and Bong Y. Koh. They certified the holdings were not acquired to change or influence control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/07/2025
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/07/2025
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/07/2025
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/07/2025
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/07/2025
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/07/2025
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/07/2025
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Koh Exhibit 24.2 Power of Attorney for Nimish Shah Exhibit 99.1 Joint Filing Agreement

FAQ

Who filed the Schedule 13G for Cybin (CYBN)?

Venrock-affiliated entities (VHCP III, VHCP Co-Investment III, VHCP EG), VHCP Management entities, and individuals Nimish Shah and Bong Y. Koh.

How many Cybin shares are reported as beneficially owned?

An aggregate of 5,111,412 common shares beneficially owned.

What percent of Cybin’s class does this represent?

A 9.99% beneficial ownership (rounded to 9.9% on cover pages).

What securities make up the reported holdings?

Common shares, pre-funded warrants, and common warrants, all limited by a 9.99% Beneficial Ownership Blocker.

What is the date of the event requiring this filing?

The event date is 10/31/2025.

How was the ownership percentage calculated?

Based on 27,616,381 shares outstanding as of 10/28/2025, 22,277,750 shares from a registered direct offering on 10/31/2025, and 1,271,162 shares issuable upon warrant exercise.

Did the filers indicate an intent to influence control of Cybin?

They certified the securities were not acquired or held to change or influence control.
Cybin Inc

NYSE:CYBN

CYBN Rankings

CYBN Latest News

CYBN Latest SEC Filings

CYBN Stock Data

302.92M
18.77M
98.65%
38.53%
10.87%
Biotechnology
Healthcare
Link
Canada
Toronto